YAP1 and hepatoblastoma: Combination of the activated form of YAP1 (YAPS127A) with either hepatoblastoma relevant NFE2L2 mutant or CTNNB1 mutant promotes liver tumorigenesis although either alone is unable to transform normal liver cells in these mouse models26.